PMCB (PharmaCyte Biotech) Common Stock: $0.00 Mil (As of Jan. 2026)


PMCB PharmaCyte Biotech Inc PMCB
34 GF Score
Price $0.77
! 2 Warning Signs
View Full Analysis

What is PharmaCyte Biotech Common Stock?

PharmaCyte Biotech PMCB +5.34% 34 Common Stock is $0.00 Mil as of Jan. 2026. GuruFocus rates PMCB with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

PharmaCyte Biotech's quarterly common stock stayed the same from Jul. 2025 ($0.00 Mil) to Oct. 2025 ($0.00 Mil) but then increased from Oct. 2025 ($0.00 Mil) to Jan. 2026 ($0.00 Mil).

PharmaCyte Biotech's annual common stock stayed the same from Apr. 2023 ($0.00 Mil) to Apr. 2024 ($0.00 Mil) and stayed the same from Apr. 2024 ($0.00 Mil) to Apr. 2025 ($0.00 Mil).

PharmaCyte Biotech Common Stock Historical Data

* Premium members only.

The historical data trend for PharmaCyte Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCyte Biotech Common Stock Chart

PharmaCyte Biotech Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PharmaCyte Biotech Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PMCB
34GF Score
PharmaCyte Biotech Inc PMCB
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaCyte Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.00 Mil mean?
PharmaCyte Biotech (PMCB) has a Common Stock of $0.00 Mil as of Jan. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PharmaCyte Biotech and its competitors.
Is PharmaCyte Biotech's Common Stock too high?
PharmaCyte Biotech's current Common Stock is $0.00 Mil. Overall, PharmaCyte Biotech has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCyte Biotech's Common Stock compare to ERNA and SYBX?
PharmaCyte Biotech's Common Stock of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PharmaCyte Biotech and its competitors. PharmaCyte Biotech's current Common Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCyte Biotech stock overvalued right now?
PharmaCyte Biotech (PMCB) has a current Common Stock of $0.00 Mil. The current Common Stock is $0.00 Mil. PharmaCyte Biotech's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For PharmaCyte Biotech (PMCB), the current Common Stock is $0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCyte Biotech Business Description

Address 3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV, USA, 89169
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
34GF Score

Get the complete analysis for PMCB

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.77
Price